Martin leads the Research & Enterprise Office at the University of Otago since mid-2018, bringing with him his extensive experience in research funding. Martin was previously at Exactis Innovation, a cancer clinical research network. He also co-founded Chlorion Pharma, a neuroscience-focused biotechnology company. As Chief Operating Officer and Vice President of Research, Martin developed novel treatments for neuropathic pain and epilepsy.
Martin brings strategic and operational expertise having secured over $100M in research financing. Martin obtained a PhD in Pharmacology andTherapeutics from McGill. His doctoral work in drug design led to the development of novel cancer therapeutics and phosphatase inhibitors.
Committee Member
